However, GNAS mutations were found exclusively in 11 of the 12 (91.6%) patients with MD-IPMN (p < 0.01), whereas KRAS mutations were identified in both diseases. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.